Tag Archives: ICPT

Top 10 High Tech Stocks To Own Right Now

Later this year, Alphabet’s (NASDAQ:GOOGL) (NASDAQ:GOOG) self-driving car company, Waymo, expects to launch a public robotaxi servicein several cities that will allow people to hail self-driving cars. Meanwhile, electric automakerTeslahas said that one of its vehicles will driveitself across the country within the next six months. And chipmaker NVIDIA (NASDAQ: NVDA) says 25 automakers are using latest version of its autonomous driving supercomputer to create fully autonomous vehicles, some of which will be available by 2021.

These announcements show just how quickly driverless car technologies are advancing. But there’s also evidence that a large portion of the general public isn’t quite ready to embrace autonomous vehicles.

According to a new J.D. Power/Miller Canfieldreport, 29% of respondents said they “probably would not” ride in a fully autonomous vehicle, and 17% said they “definitely would not.” Even when those skeptical 46% of respondents were specifically asked how they’d feel about using anautonomous vehicle if it met all government safety standards, 78% said they’d still be reluctant to set foot in one.

Top 10 High Tech Stocks To Own Right Now: National Steel Corporation(SID)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Companhia Siderurgica Nacional (NYSE:SID)’s share price hit a new 52-week low during trading on Tuesday . The company traded as low as $1.95 and last traded at $1.99, with a volume of 131251 shares. The stock had previously closed at $2.02.

  • [By Dan Caplinger]

    Monday began the week on a solid note for the stock market, with the Dow Jones Industrial Average posting another triple-digit gain as the Nasdaq Compositeclosed at a record high. Despite ongoing nervousness regarding trade, most investors remain convinced that the strong U.S. economy will be able to lead the way forward, pointing to Friday’s employment report as the latest evidence of sustainable momentum. Good news regarding a host of companies both in the U.S. and abroad also helped buoy the market’s mood. Fossil Group (NASDAQ:FOSL), Companhia Siderurgica Nacional (NYSE:SID), and Immunomedics (NASDAQ:IMMU) were among the best performers on the day. Here’s why they did so well.

  • [By Ethan Ryder]

    Daiwa Securities Group Inc. reduced its stake in shares of Companhia Sider煤rgica Nacional (NYSE:SID) by 10.2% during the 1st quarter, Holdings Channel reports. The firm owned 374,200 shares of the basic materials company’s stock after selling 42,600 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Companhia Sider煤rgica Nacional were worth $984,000 at the end of the most recent reporting period.

  • [By Rich Smith]

    Brazilian steelmaker Companhia Siderurgica Nacional (NYSE:SID) stock lost 20% of its value in last month’s sell-off, hurt by a shareholder dispute with management and (probably) continued generally negative sentiment regarding South American stocks. This morning, however, shares of CSN are turning around, and trading up 13% as of 12:30 p.m. EDT.

  • [By Rich Smith]

    Confirming that this was not an “oil story” but a “Brazil story,” shares of Brazilian airline Azul SA (NYSE:AZUL) and Brazilian steel company Companhia Siderurgica Nacional (NYSE:SID) likewise declined steeply — closing down 7.2% and 4.8%, respectively. Overall, the Brazilian Ibovespa benchmark stock index closed down 3.7%, after falling as much as 6% in trading earlier in the day.

Top 10 High Tech Stocks To Own Right Now: Independent Bank Corporation(IBCP)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Independent Bank Co.(MI) (IBCP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Independent Bank (IBCP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Independent Bank Co.(MI) (IBCP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    BidaskClub lowered shares of Independent Bank (NASDAQ:IBCP) from a buy rating to a hold rating in a research note issued to investors on Friday.

    IBCP has been the topic of several other reports. Zacks Investment Research lowered Independent Bank from a buy rating to a hold rating in a report on Wednesday, February 28th. ValuEngine raised Independent Bank from a hold rating to a buy rating in a report on Tuesday, April 24th. Boenning Scattergood reissued a hold rating on shares of Independent Bank in a report on Tuesday, April 24th. Finally, Hovde Group set a $26.00 price objective on Independent Bank and gave the company a hold rating in a report on Tuesday, April 24th. Five analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Independent Bank presently has a consensus rating of Hold and a consensus target price of $25.25.

Top 10 High Tech Stocks To Own Right Now: CHS Inc(CHSCL)

Advisors’ Opinion:

  • [By Joseph Griffin]

    CHS (NASDAQ:CHSCL) was upgraded by analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research report issued on Friday.

Top 10 High Tech Stocks To Own Right Now: Rent-A-Center Inc.(RCII)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Monday was a weak day for the stock market, with most major benchmarks losing ground. Further concerns about the potential for a deepening divide between the U.S. and China weighed on sentiment, and some also fear that steadily rising interest rates could eventually put pressure on stocks. Yet some companies still had good news that sent their individual shares higher. Rent-A-Center (NASDAQ:RCII), PTC Therapeutics (NASDAQ:PTCT), and Dropbox (NASDAQ:DBX) were among the best performers on the day. Here’s why they did so well.

  • [By ]

    Engaged Capital maintained large positions in Rent-A-Center (RCII) , TiVo (TIVO) , Hain Celestial (HAIN) , SunOpta and Jamba Inc. (JMBA) , all companies that have either previously been targeted by Welling or currently are in his cross-hairs.

  • [By Logan Wallace]

    AerCap (NYSE: AER) and Rent-A-Center (NASDAQ:RCII) are both finance companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, risk, analyst recommendations and valuation.

  • [By Chris Lange]

    Rent-A-Center Inc. (NASDAQ: RCII) shares made an incredible gain on Monday after the company announced that it would be taken private by Vintage Rodeo Parent, an affiliate of Vintage Capital Management.

Top 10 High Tech Stocks To Own Right Now: CSX Corporation(CSX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on CSX (CSX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Hill]

    But there was more upbeat news elsewhere, with No. 3 airline United Continental(NYSE:UAL) beating on earnings and freight rail titan CSX(NASDAQ:CSX) delivering record first-quarter numbers. Also on the rapid growth train: Intuitive Surgical(NASDAQ:ISRG), whose da Vinci systems are selling at an impressive rate. And speaking of sales of tech products, the guys close out the episode by explaining why it’s a win-win that Amazon.com(NASDAQ:AMZN) and Best Buy(NYSE:BBY) are joining forces to sell smart TVs.

  • [By ]

    CSX Corp. (CSX) shares jumped in after-hours trading Tuesday, April 17, after reporting a top- and bottom-line beat for the first quarter, driven by lower costs and restructuring expenses.

  • [By Asit Sharma]

    CSX Corporation (NASDAQ:CSX)surprised investors with extremely healthy results on its release of first-quarter 2018 earnings Tuesday after the markets closed. While lower volumes compressed the company’s top line, leading to essentially flat revenue of $2.9 billion, net income soared 92%, to $695 million, due to cost-cutting and the fruit of productivity initiatives. Shares responded in kind, as CSX stock gained nearly 8% in Wednesday’s trading session.

  • [By Ethan Ryder]

    CSX Co. (NASDAQ:CSX) CEO James M. Foote bought 5,000 shares of the firm’s stock in a transaction on Wednesday, May 2nd. The stock was acquired at an average price of $59.91 per share, for a total transaction of $299,550.00. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Top 10 High Tech Stocks To Own Right Now: Avery Dennison Corporation(AVY)

Advisors’ Opinion:

  • [By Logan Wallace]

    Oppenheimer Asset Management Inc. decreased its position in Avery Dennison Corp (NYSE:AVY) by 9.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 11,671 shares of the industrial products company’s stock after selling 1,265 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Avery Dennison were worth $1,240,000 at the end of the most recent quarter.

  • [By Max Byerly]

    These are some of the news articles that may have impacted Accern Sentiment Analysis’s analysis:

    Get Avery Dennison alerts:

    Avery Dennison (AVY) Shares Cross Below 200 DMA (nasdaq.com) Avery Dennison (AVY) Given Average Rating of “Buy” by Brokerages (americanbankingnews.com) Concern in Framingham about environmental contamination (metrowestdailynews.com) Avery Dennison (AVY) Rating Lowered to Hold at Zacks Investment Research (americanbankingnews.com) Avery Dennison (AVY) Upgraded at Zacks Investment Research (americanbankingnews.com)

    Several equities research analysts recently commented on AVY shares. Citigroup dropped their price objective on Avery Dennison from $140.00 to $125.00 and set a “buy” rating on the stock in a research report on Thursday, April 5th. Zacks Investment Research raised Avery Dennison from a “hold” rating to a “buy” rating and set a $132.00 price objective on the stock in a research report on Monday, February 5th. UBS started coverage on Avery Dennison in a research report on Thursday, January 18th. They set a “buy” rating and a $135.00 price objective on the stock. Bank of America increased their price objective on Avery Dennison from $128.00 to $133.00 and gave the company a “buy” rating in a research report on Thursday, February 1st. Finally, KeyCorp reaffirmed a “hold” rating on shares of Avery Dennison in a research report on Wednesday, April 25th. Five research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $123.00.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Avery Dennison (AVY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Avery Dennison (AVY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 High Tech Stocks To Own Right Now: Intercept Pharmaceuticals, Inc.(ICPT)

Advisors’ Opinion:

  • [By George Budwell]

    If that line holds true, this emerging space should be able to support multiple new drugs, meaning that the current leaders in the field –Intercept Pharmceuticals (NASDAQ:ICPT) and Genfit — probably won’t be able to monopolize the market before other competitors like Viking get their drugs past the FDA. In fact, this market is so large it could feasibly support several blockbuster level products.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Intercept Pharmaceuticals (ICPT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Sean Williams]

    As you can see, there’s a lot of excitement in the NASH space at the moment, and plenty of big drug stocks are itching to add a promising NASH drug to their product pipelines. But one name that continues to be left out in the cold is Intercept Pharmaceuticals (NASDAQ:ICPT).

  • [By Max Byerly]

    News headlines about Intercept Pharmaceuticals (NASDAQ:ICPT) have trended somewhat positive recently, Accern Sentiment Analysis reports. The research group scores the sentiment of press coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Intercept Pharmaceuticals earned a news impact score of 0.12 on Accern’s scale. Accern also gave news articles about the biopharmaceutical company an impact score of 46.6381898611919 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

  • [By Sean Williams, Chuck Saletta, and Brian Feroldi]

    With this in mind, we picked the brains of three Motley Fool investors to gauge what biotech stock they believe investors should consider buying right now. Topping the list were mid-caps Intercept Pharmaceuticals (NASDAQ:ICPT) and Xencor (NASDAQ:XNCR), as well as biotech blue-chip Celgene (NASDAQ:CELG).

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

Top 10 High Tech Stocks To Own Right Now: DCT Industrial Trust Inc(DCT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its holdings in shares of DCT Industrial Trust Inc (NYSE:DCT) by 7.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 14,570 shares of the real estate investment trust’s stock after acquiring an additional 1,044 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in DCT Industrial Trust were worth $821,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Stephan Byrd]

    Daiwa Securities Group Inc. lifted its holdings in DCT Industrial Trust Inc (NYSE:DCT) by 25.5% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 19,700 shares of the real estate investment trust’s stock after purchasing an additional 4,000 shares during the period. Daiwa Securities Group Inc.’s holdings in DCT Industrial Trust were worth $1,110,000 at the end of the most recent quarter.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on DCT Industrial Trust (DCT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Teza Capital Management LLC bought a new stake in DCT Industrial Trust Inc (NYSE:DCT) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 6,379 shares of the real estate investment trust’s stock, valued at approximately $359,000.

Top 10 High Tech Stocks To Own Right Now: (LGEAF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Coherent’s ELA deposition technology for LTPS backplane isn’t used in OLED TVs, where LG (OTC:LGEAF) uses metal oxide backpanes. There was some worry by analysts whether that technology could migrate to the smartphone panel market which CEO Ambroseo could not dispel entirely, but he argued that it has not been demonstrated suitable for handsets or battery-powered devices at this point.

Top 10 High Tech Stocks To Own Right Now: Nexstar Broadcasting Group Inc.(NXST)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Nexstar Media Group (NASDAQ:NXST) had its price target cut by B. Riley to $87.00. They currently have a buy rating on the stock.

    Ralph Lauren (NYSE:RL) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Ralph Lauren outperformed the industry in the past six months backed by robust bottom-line performance in recent quarters. Notably, third-quarter fiscal 2018 marked the company’s 12th consecutive earnings beat while sales lagged estimates after a beat in the previous quarter. Additionally, the company’s Way Forward Plan is on track, and it remains keen on bolstering digital and international presence. Also, the company has been gaining from favorable geographic and channel mix shifts along with lower promotions and reduced product costs. Further, management adjusted fiscal 2018 outlook to account for the positive currency rates, which are likely to aid revenues and operating margins. However, its North America business continues to suffer due to distribution and brand exits, planned reduction in shipments and promotions to enhance the quality of sales, and lower customer demand.”

  • [By Stephan Byrd]

    Nexstar Media Group (NASDAQ: NXST) and Liberty Media Formula One Series C (NASDAQ:FWONK) are both mid-cap consumer discretionary companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, profitability and risk.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Nexstar Media Group (NXST)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Heal Care Stocks To Invest In Right Now

LISTEN TO ARTICLE 2:14 SHARE THIS ARTICLE Facebook Twitter LinkedIn Email

If cryptocurrency markets want to move from the fringes of finance into the mainstream, they’ll need to make some changes.

That’s according to a new report on best practices for digital-asset exchanges, which have been dogged by everything from market manipulation to cyberthefts and questionable data. Authored by the Asia Securities Industry & Financial Markets Association, whose members include Goldman Sachs Group Inc. and BlackRock Inc., the report is the first of its kind by a major financial sector trade group.

Best Heal Care Stocks To Invest In Right Now: Cullen/Frost Bankers, Inc.(CFR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Cullen/Frost Bankers (CFR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Cullen/Frost Bankers (CFR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Anders Bylund, Jason Hall, Danny Vena, Jordan Wathen, and Brian Feroldi]

    In that spirit, we asked a few of our Motley Fool investors what they see as the best investment ideas at the start of July, 2018. They were quick to suggest Chinese e-commerce giantBaidu(NASDAQ:BIDU), coffee giant Starbucks (NASDAQ:SBUX), clean energy specialist TerraForm Power (NASDAQ:TERP), semiconductor veteran Intel, (NASDAQ:INTC), and Texan bankCullen/Frost Bankers(NYSE:CFR).

  • [By Ethan Ryder]

    News articles about Cullen/Frost Bankers (NYSE:CFR) have been trending somewhat positive on Saturday, according to Accern Sentiment Analysis. The research firm ranks the sentiment of news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cullen/Frost Bankers earned a news sentiment score of 0.01 on Accern’s scale. Accern also assigned news stories about the bank an impact score of 46.1866283388257 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

  • [By Joseph Griffin]

    BlackRock Inc. grew its stake in shares of Cullen/Frost Bankers, Inc. (NYSE:CFR) by 2.8% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 5,251,719 shares of the bank’s stock after acquiring an additional 140,956 shares during the period. BlackRock Inc. owned about 8.23% of Cullen/Frost Bankers worth $557,051,000 at the end of the most recent quarter.

Best Heal Care Stocks To Invest In Right Now: United Fire Group, Inc(UFCS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    United Fire Group (NASDAQ:UFCS) was downgraded by stock analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Friday.

  • [By Lee Jackson]

    United Fire Group Inc. (NASDAQ: UFCS) was downgraded to hold from buy at Sandler ONeill. The 52-week trading range for the shares has been $38.95 to $58.46. The stock closed Monday at $56, so this could be another valuation call.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on United Fire Group (UFCS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Heal Care Stocks To Invest In Right Now: KLX Inc.(KLXI)

Advisors’ Opinion:

  • [By Logan Wallace]

    OppenheimerFunds Inc. decreased its position in KLX Inc (NASDAQ:KLXI) by 16.2% in the 1st quarter, Holdings Channel reports. The firm owned 7,067 shares of the aerospace company’s stock after selling 1,367 shares during the period. OppenheimerFunds Inc.’s holdings in KLX were worth $502,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Max Byerly]

    BidaskClub downgraded shares of KLX (NASDAQ:KLXI) from a buy rating to a hold rating in a report released on Tuesday morning.

    KLXI has been the subject of several other reports. SunTrust Banks cut shares of KLX from a buy rating to a hold rating and set a $53.00 target price for the company. in a report on Wednesday, May 2nd. Zacks Investment Research cut shares of KLX from a buy rating to a hold rating in a report on Saturday, February 17th. TheStreet cut shares of KLX from a b rating to a c+ rating in a report on Tuesday, March 6th. Finally, Jefferies Group upgraded shares of KLX from a hold rating to a buy rating in a report on Wednesday, March 7th. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The company presently has an average rating of Hold and a consensus target price of $66.50.

  • [By Lou Whiteman]

    Wesco Aircraft (NYSE:WAIR) has found it difficult to compete against archrival KLX (NASDAQ:KLXI) in recent years, suspending guidance last year and thenreporting an unexpected full-fiscal-year loss. Wesco has been mounting a comeback lately, but the company’s challenges are set to intensify after Boeing (NYSE:BA) announced plans to buy KLX for $4.25 billion.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on KLX (KLXI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Heal Care Stocks To Invest In Right Now: Intercept Pharmaceuticals, Inc.(ICPT)

Advisors’ Opinion:

  • [By Max Byerly]

    News headlines about Intercept Pharmaceuticals (NASDAQ:ICPT) have trended somewhat positive recently, Accern Sentiment Analysis reports. The research group scores the sentiment of press coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Intercept Pharmaceuticals earned a news impact score of 0.12 on Accern’s scale. Accern also gave news articles about the biopharmaceutical company an impact score of 46.6381898611919 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Sean Williams, Chuck Saletta, and Brian Feroldi]

    With this in mind, we picked the brains of three Motley Fool investors to gauge what biotech stock they believe investors should consider buying right now. Topping the list were mid-caps Intercept Pharmaceuticals (NASDAQ:ICPT) and Xencor (NASDAQ:XNCR), as well as biotech blue-chip Celgene (NASDAQ:CELG).

Best Heal Care Stocks To Invest In Right Now: United States Steel Corporation(X)

Advisors’ Opinion:

  • [By ]

    Names like U.S. Steel (NYSE: X), Nucor Corp (NYSE: NUE), and AK Steel Holdings (NYSE: AKS) all had an initial bump higher upon the announcement of the tariffs. But the excitement soon faded, with prices plunging back lower. The market is making it clear that tariffs of any kind are not welcome!

  • [By Joseph Griffin]

    Commerzbank Aktiengesellschaft FI trimmed its holdings in shares of U.S. Steel (NYSE:X) by 3.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 121,345 shares of the basic materials company’s stock after selling 4,606 shares during the period. Commerzbank Aktiengesellschaft FI’s holdings in U.S. Steel were worth $4,270,000 as of its most recent SEC filing.

  • [By ]

    You can see why Century Aluminum (Nasdaq: CENX) commended the President for “acting swiftly and boldly to save the American aluminum industry.” The company intends to ramp up operations at its smelter in Hawesville, Kentucky, putting 300 people back to work. In Illinois, US Steel (NYSE: X) is restarting a blast furnace that will employ at least 500 new workers.

  • [By Matthew DiLallo]

    Shares of U.S. Steel (NYSE:X) have been red-hot over the past year, surging nearly 60%. Driving those gains has been a significant improvement in the company’s earnings due to higher steel prices. In the first quarter, the steelmaker reported $57 million, or $0.32 per share, of adjusted earnings, which was a vast improvement from the adjusted loss of $145 million, or $0.83 per share, it reported in the year-ago quarter.

Top 5 Undervalued Stocks To Buy For 2018

Shares of Gilead Sciences (GILD) have risen by over 10% since my initial article in April which called the stock a core buy in biotech with several value drivers.

GILD data by YCharts

Long time readers know that I麓m a fan of value catalyst plays, as being undervalued by itself is not a reason for me to be interested in a stock. Too often, selections we deem 篓cheap篓 or a 篓buy the dip篓 play can continue to stay cheap or head south unless there is a catalyst present to turn the ship around.

In my July update piece titled 篓Vosevi EU Approval Just One Of Several Catalysts On The Way篓 we looked at several material events that could cause shares to surge higher. While they initially did just that, unfortunately a pullback in the biotech sector brought the stock back to levels it was previously at.

Top 5 Undervalued Stocks To Buy For 2018: First Trust NASDAQ-100- Technology Index Fund(QTEC)

Advisors’ Opinion:

  • [By Zacks]

    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
     
    Amazon.com, Inc. (NASDAQ: AMZN): Free Stock Analysis Report
     
    Netflix, Inc. (NASDAQ: NFLX): Free Stock Analysis Report
     
    Facebook, Inc. (NASDAQ: FB): Free Stock Analysis Report
     
    Alphabet Inc. (NASDAQ: GOOGL): Free Stock Analysis Report
     
    Apple Inc. (NASDAQ: AAPL): Free Stock Analysis Report
     
    SPDR-TECH SELS (ETF:XLK): ETF Research Reports
     
    NASDAQ-100 SHRS (NASDAQ: QQQ): ETF Research Reports
     
    SPDR-SP 500 TR (ETF:SPY): ETF Research Reports
     
    PWRSH-DYN SEMI (ETF:PSI): ETF Research Reports
     
    ISHARS-NA TEC-S (ETF:IGV): ETF Research Reports
     
    FIRST N-100 TEC (NASDAQ: QTEC): ETF Research Reports
     
    FT-TECH ALPHA (ETF:FXL): ETF Research Reports
     
    FT-NDQ SEMICON (FTXL): ETF Research Reports
     
    NVIDIA Corporation (NASDAQ: NVDA): Free Stock Analysis Report
     
    Macy's Inc (NYSE: M): Free Stock Analysis Report
     
    To read this article on Zacks.com click here.
     
    Zacks Investment Research
     
    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Top 5 Undervalued Stocks To Buy For 2018: Nutraceutical International Corporation(NUTR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Non-cyclical consumer goods & services sector was the top gainer in the US market on Monday. Top gainers in the sector included Nutraceutical Int'l Corp. (NASDAQ: NUTR), BRF SA (ADR) (NYSE: BRFS), and Chefs' Warehouse Inc (NASDAQ: CHEF).

Top 5 Undervalued Stocks To Buy For 2018: Intercept Pharmaceuticals, Inc.(ICPT)

Advisors’ Opinion:

  • [By Paul Ausick]

    Intercept Pharmaceuticals Inc. (NASDAQ: ICPT) dropped more than 17% Friday to post a new 52-week low of $60.97 after closing Thursday at $73.70. The 52-week high is $172.75. Volume of more than 10 million shares traded was about 12 times the daily average. The FDA on Thursday issued a warning letter on the company’s liver disease treatment.

  • [By Peter Graham]

    Small cap liver biopharmaceutical stock Intercept Pharmaceuticals Inc (NASDAQ: ICPT) reportedQ2 2017 earnings before the market opened on Monday with both the top and bottom lines beating expectations plus the Companyreported that amid-stage clinical trial met its primary endpoint; but sharesended the day down13.26%. Intercept Pharmaceuticals recognized $30.4 million of net sales of Ocaliva for Q2 2017 versus $75k and a net loss of $86.6 million versus a net loss of $77.3 million. Ocaliva was approved by the U.S.FDA in May 2016 for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA or as monotherapy in adults unable to tolerate UDCA. As of June 30, 2017,the Companyhad cash, cash equivalents and investment securities available for sale of approximately $550.3 million versus$689.4 million as of December 31, 2016. The CEO commented:

Top 5 Undervalued Stocks To Buy For 2018: iShares MSCI EAFE (EFA)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of David Swensen’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=David+Swensen

    These are the top 5 holdings of David SwensenJBG SMITH Properties (JBGS) – 5,145,068 shares, 40.61% of the total portfolio. New PositionAntero Midstream GP LP (AMGP) – 5,769,780 shares, 27.25% of the total portfolio. Shares added by 3.89%Antero Resources Corp (AR) – 3,674,487 shares, 16.87% of the total portfolio. Shares reduced by 6.35%iShares MSCI EAFE (EFA) – 967,022 shares, 15.28% of the total portfolio. Shares reduced by 61.75%iShares China Large-Cap (FXI) – 0 shares, 0% of the

  • [By WWW.MONEYSHOW.COM]

    Meanwhile, international stocks look better than U.S. stocks. The iShares MSCI EAFE Index Fund (EFA) is an ETF that offers international exposure to developed countries in Western Europe, Japan and Australia.

  • [By WWW.GURUFOCUS.COM]

    For the details of SWISS RE LTD’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=SWISS+RE+LTD

    These are the top 5 holdings of SWISS RE LTDiShares Core S&P 500 (IVV) – 1,274,000 shares, 41.43% of the total portfolio. Shares added by 114.84%SPDR S&P 500 (SPY) – 1,192,350 shares, 38.52% of the total portfolio. Shares added by 158.64%iShares MSCI EAFE (EFA) – 1,043,001 shares, 8.7% of the total portfolio. Shares added by 12.39%iShares Floating Rate Bond (FLOT) – 1,000,000 shares, 7.33% of the total portfolio. NewStar Financial Inc (NEWS) – 3,000,000 shares, 4.01%

Top 5 Undervalued Stocks To Buy For 2018: Arista Networks, Inc.(ANET)

Advisors’ Opinion:

  • [By Simon Erickson]

    Arista Networks (NYSE:ANET) founder/Chairman Andy Bechtolsheim became a Silicon Valley legend after being one of the first investors in the company now called Alphabet (NASDAQ:GOOGL), cutting the company a $100,000 check in 1998 before it had even formally selected a name (he confirmed this investment has personally netted him more than $1 billion).

    Arista’s customer count has increased sixfold during the past four years (from 570 in 2011 to more than 3,500 today) and their market share in high-speed data center switching has increased from 3% to 12% during the same time frame. Bechtolsheim owns 19% of Arista’s shares, with insiders collectively owning more than 44%. Due to massive amounts of data being transferred across the Internet (thanks to high-definition video, genomic sequencing, and a ton of other formats), investment in cloud-computing infrastructure is estimated to grow from $32.6 billion in 2015 to $53.1 billion by 2019. 

  • [By Lisa Levin]

    Shares of Arista Networks Inc (NYSE: ANET) got a boost, shooting up 17 percent to $117.47 after the company reported better-than-expected results for its fourth quarter and issued a strong outlook for the current quarter.

  • [By Billy Duberstein]

    Furthermore, if the company were thinking along these lines it would be due to competitive pressures. For years, Cisco’s switching software was only available on its own high-margin hardware; however, the data center switching industry is changing, as competitors like Arista Networks (NYSE:ANET) are winning market share by offering low-cost switches with high functionality. In the past year or two, though, an even greater threat to the industry has emerged, as smaller networking companies started selling stand-alone software that could be run on low-end “whitebox” switches made by low-cost Asian vendors.

Hot Safest Stocks To Buy For 2018

Closed-end funds have become popular in recent years as bond yields have dropped precipitously. As a result, income investors have gone further out on the yield curve to find the kind of yields with CEFs they used to enjoy in the days when bonds were offering higher interest payments.

Source: Shutterstock

One of the things my stock advisory newsletter, The Liberty Portfolio, does is find securities that deliver better risk-adjusted returns than you’ll find in the market. This is not an easy task because most investors don’t realize just how much risk they are taking on so-called “safe investments,” even with CEFs.

Hot Safest Stocks To Buy For 2018: Costco Wholesale Corporation(COST)

Advisors’ Opinion:

  • [By Shanthi Rexaline]

    Kroger Co (NYSE: KR) and Costco Wholesale Corporation (NASDAQ: COST) are among the other retailers that significantly benefit from SNAP.

    Although estimates are not available, beverage giants such as PepsiCo, Inc. (NYSE: PEP), Dr Pepper Snapple Group Inc. (NYSE: DPS) and The Coca-Cola Co (NYSE: KO) also benefit from SNAP. When there was a move in 2011 to bring about restrictions on SNAP purchases, Pepsi reportedly spent $750,000 in the third quarter of 2011 on lobbying alone.

  • [By Ben Levisohn]

    Costco Wholesale (COST) has risen 9% during the past 12 months of trading, less than half the S&P 500′s 21% gain during the same period. But that underperformance didn’t stop Barron’s Teresa Rivas from urging investors to “put Costco in your shopping cart” in December, or Oppenheimer from calling Costco one of the most intriguing names in large-cap retail last week. Now Goldman Sachs analyst Matthew Fassler and team have added Costco to the firm’s Conviction List, while reiterating their Buy rating. They explain why:

    Getty Images

    We believe the company is on the cusp of the earnings acceleration we cited when we upgraded the stock to Buy last spring, aided by its recent credit card deal both the incremental traffic associated with more attractive cashback incentives and expense cushion associated with new terms. We also like the firms attractive positioning as a low-cost/low-priced operator in the challenging retail environment. Our estimates stand above consensus. The stock is trading below long-run relative P/E averages despite the anticipated earnings recovery. Our $187, 12-month price target implies 14% upside.

    Shares of Costco Wholesale aren’t getting a boost from the upgrade this morning, however. Its shares have dipped 0.2% to $163.98 at 10:17 a.m. today.

  • [By Dan Caplinger]

    Retail giant Costco Wholesale (NASDAQ:COST) has been an innovator in the big-box retail industry, pioneering and refining the warehouse-shopping concept and honing it into a hugely successful business. Yet even Costco has run into some challenges lately, and coming into Wednesday’s fiscal second-quarter financial report, Costco investors wanted reassurances that the warehouse retailer would be able to sustain its growth. On that front, the retailer disappointed its investors, posting a substantial decline in net income that spurred the company to take action to shore up its main profit center going forward.

  • [By Daniel B. Kline]

    Costco (NASDAQ:COST) continues to squander an opportunity by operating as if the internet has not become a major factor in retail.

    The company has proven resilient in the face of digital competitors led by Amazon (NASDAQ:AMZN). While other retailers are shuttering stores, losing sales, and generally fighting for survival, the warehouse chain has not had that problem.

  • [By WWW.THESTREET.COM]

    This one could be the easiest of advances, both because credit losses are down big and because its credit-card brethren — Capital One Financial, Discover, Visa (V) and MasterCard (MA) — have all had significant rallies. I actually regard this stock as inexpensive and think it can be bought here now that it has fully absorbed the loss of the Costco (COST) business to Visa and Citigroup (C) .

Hot Safest Stocks To Buy For 2018: Move Inc.(MOVE)

Advisors’ Opinion:

  • [By Renu Singh]

    Aruba Networks (ARUN) is a leading provider of next-generation network access solutions for mobile enterprise. The company’s Mobile Virtual Enterprise (MOVE) architecture unifies wired and wireless network infrastructures into one seamless access solution for corporate headquarters, mobile business professionals, remote workers and guests. This unified approach to access networks enables IT organizations and users to securely address the Bring Your Own Device (BYOD) phenomenon, dramatically improving productivity and lowering capital and operational costs.

Hot Safest Stocks To Buy For 2018: Square, Inc.(SQ)

Advisors’ Opinion:

  • [By Leo Sun]

    Dorsey subsequently co-founded online payments company Square (NYSE:SQ) in 2009, and he was promoted from passive member to executive chairman of Twitter’s board in 2010, after Dick Costolo replaced Evan Williams.

  • [By Chris Lange]

    Square, Inc. (NYSE: SQ) reported second-quarter financial results after markets closed Wednesday. The company said that it had a $0.07 in earnings per share (EPS) and $552 million in revenue, compared with consensus estimates from Thomson Reuters that called for a net loss of $0.05 per share and $536.27 million in revenue. The same period from last year had a net loss of $0.08 per share and $438.53 million in revenue.

  • [By Elizabeth Balboa]

    Western Digital Corp (NASDAQ: WDC) lost 16 percent over the last eight trading sessions, and Square Inc (NYSE: SQ), after a 264-percent run, conceded 24 percent.

Hot Safest Stocks To Buy For 2018: Intercept Pharmaceuticals, Inc.(ICPT)

Advisors’ Opinion:

  • [By Paul Ausick]

    Intercept Pharmaceuticals Inc. (NASDAQ: ICPT) dropped more than 17% Friday to post a new 52-week low of $60.97 after closing Thursday at $73.70. The 52-week high is $172.75. Volume of more than 10 million shares traded was about 12 times the daily average. The FDA on Thursday issued a warning letter on the company’s liver disease treatment.

  • [By Peter Graham]

    Small cap liver biopharmaceutical stock Intercept Pharmaceuticals Inc (NASDAQ: ICPT) reportedQ2 2017 earnings before the market opened on Monday with both the top and bottom lines beating expectations plus the Companyreported that amid-stage clinical trial met its primary endpoint; but sharesended the day down13.26%. Intercept Pharmaceuticals recognized $30.4 million of net sales of Ocaliva for Q2 2017 versus $75k and a net loss of $86.6 million versus a net loss of $77.3 million. Ocaliva was approved by the U.S.FDA in May 2016 for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA or as monotherapy in adults unable to tolerate UDCA. As of June 30, 2017,the Companyhad cash, cash equivalents and investment securities available for sale of approximately $550.3 million versus$689.4 million as of December 31, 2016. The CEO commented:

Hot Safest Stocks To Buy For 2018: American Superconductor Corporation(AMSC)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Marathon Patent Group Inc (NASDAQ: MARA) shares surged 30.2 percent to $5.01 after dropping 40.86 percent on Tuesday. Marathon Patent Group filed for sale of 1.85 million shares of common stock by selling stockholders.
    Capricor Therapeutics Inc (NASDAQ: CAPR) shares jumped 17.2 percent to $2.25 after the company reported the FDA clearance of Investigational New Drug application for CAP-1002.
    Rite Aid Corporation (NYSE: RAD) gained 13.2 percent to $2.15 following 16.5 percent rally on Tuesday.
    Photronics, Inc. (NASDAQ: PLAB) shares climbed 11.8 percent to $10.45 after the company reported stronger-than-expected earnings for its fourth quarter.
    China Distance Education Hldgs Ltd (ADR) (NYSE: DL) shares surged 11.3 percent to $8.67. China Distance Education reported Q4 profit of $5.9 million on revenue of $41.7 million.
    Cytokinetics, Inc. (NASDAQ: CYTK) shares gained 11 percent to $8.05 after falling 7.05 percent on Tuesday.
    Ooma Inc (NYSE: OOMA) shares surged 8.5 percent to $10.85 as the company posted strong Q3 results.
    Nuance Communications Inc. (NASDAQ: NUAN) climbed 8 percent to $17.12 after the company reported stronger-than-expected results for its fourth quarter on Tuesday.
    American Superconductor Corporation (NASDAQ: AMSC) surged 7.8 percent to $3.59 after the company reported $8 million in D-VAR system orders.
    Thermon Group Holdings Inc (NYSE: THR) rose 6.3 percent to $24.17. William Blair upgraded Thermon Group from Market Perform to Outperform.
    Domino's Pizza, Inc. (NYSE: DPZ) surged 6.1 percent to $182.88. Nomura upgraded Domino's from Neutral to Buy.
    Xencor Inc (NASDAQ: XNCR) rose 5.9 percent to $21.17. Cantor Fitzgerald initiated coverage on Xencor with an Overweight rating.
    Idera Pharmaceuticals Inc (NASDAQ: IDRA) gained 5.1 percent to $2.28 after the company disclosed that it has been granted FDA Fast Track designation for IMO-2125.
    Regal Entertainment Group (NYSE: RGC) gained 5.1 percent to
  • [By William Romov]

    According to S&P Capital IQ, shares of TTOO have an average price target of $5.75, representing 40.24% upside from current levels.

    Penny Stocks to Buy for December 2017, No. 4: American Superconductor Corp. (Nasdaq: AMSC)

    Massachusetts-based American Superconductor Corp. (Nasdaq: AMSC) makes two-megawatt wind turbines under the Windtec Solutions brand. The company also sells products and services to connect electricity-generating equipment with the power grid.

Hot Safest Stocks To Buy For 2018: L Brands, Inc.(LB)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    On Thursday's edition of PreMarket Prep, we're discussing earnings from Wal-Mart Stores Inc (NYSE: WMT), Cisco Systems Inc. (NASDAQ: CSCO) and L Brands Inc (NYSE: LB). Plus Nelson Peltz's battle with Proctor & Gamble Co (NYSE: PG) and the biggest ratings changes of the day. 

  • [By Paul Ausick]

    L Brands Inc. (NYSE: LB) posted a new 52-week low of $43.09 on Wednesday, down about 1.6% compared with Tuesday’s closing price of $43.77. The stock’s 52-week high is $87.16. Volume was about 20% above the daily average of around 4.2 million shares. The company received a downgrade at Citigroup on Tuesday and is being included among those retailers that have too many stores.

  • [By Chris Lange]

    With Christmas just around the corner and Black Friday already in the bag, holiday shopping is picking up. And this is especially true at L Brands Inc. (NYSE: LB), which recently reported its November sales.

Top 10 Medical Stocks For 2018

On Thursday, our Under the Radar Moversnewsletter suggestedshorting small cap pet medical insurance stock Trupanion Inc (NASDAQ: TRUP):

The big trigger for our bet against Trupanion is today’s decisive cross under the 200-day moving average lie (green), which also yanked TRUP under a horizontal floor around $14.20. The kicker/clincher is the fact that the 20-day moving average line pulled under its 100-day line last week. As you can see on the chart though, the volume trend — as evidenced by the falling Chaikin Money Flow indicator — has been bearish for a while. This tumble is just the materialization of that bearish undertow, but the selling could pick up in earnest now that this technical blow has been dealt.

Our Under the Radar Moversnewsletter has a more detailed discussion about Trupanion Incs techncial chart and a potential shorting strategy:

Top 10 Medical Stocks For 2018: Heartware International, Inc.(HTWR)

Advisors’ Opinion:

  • [By Spencer Israel]

    4. HeartWare International Inc (NASDAQ: HTWR) – The heart device maker agreed to be acquired by Medtronic for $58 per share in cash two weeks ago. Prior to that the stock had been trading just above $30. 

Top 10 Medical Stocks For 2018: Capstead Mortgage Corporation(CMO)

Advisors’ Opinion:

  • [By Amanda Alix]

    As the spread between short-term and long-terminterest rates began to contract, strangling profits, competition for MBSes also caused prices to rise. Other agency mREITs were nervous, too. CYS Investments (NYSE: CYS  ) noted at the time that QE3 turned the Federal Reserve into the sector’s biggest rival for mortgage bonds, and as spreads began to shrink, so did dividends. By December of last year, Annaly, Armour, and Capstead Mortgage (NYSE: CMO  ) had all trimmed their payouts.

Top 10 Medical Stocks For 2018: Tableau Software, Inc.(DATA)

Advisors’ Opinion:

  • [By Monica Gerson]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Monday’s regular session.

    Pier 1 Imports Inc (NYSE: PIR) Dec16 5.0 Puts Sweep: 1191 @ ASK $0.80: 1354 traded vs 102 OI: $5.32 Ref
    Alcoa Inc (NYSE: AA) Jul16 9.5 Puts Sweep: 1494 @ ASK $0.13: 14k traded vs 6682 OI: $10.09 Ref
    Sarepta Therapeutics Inc (NASDAQ: SRPT) Jul16 10.0 Puts: 3536 @ ASK $0.50: 5506 traded vs 54k OI: Earnings 8/4 $22.50 Ref
    Tableau Software Inc (NYSE: DATA) Jul16 47.5 Puts Sweep: 837 @ ASK $0.30: 995 traded vs 37 OI: Earnings 8/3 $50.60 Ref
    Yandex NV (NASDAQ: YNDX) Aug16 18.0 Puts Sweep: 532 @ ASK $0.30: 2143 traded vs 78 OI: Earnings 7/28 Before Open $22.02 Ref
    Wolverine World Wide, Inc. (NYSE: WWW) Aug16 22.5 Puts: 719 @ ASK $1.35: 1032 traded vs 0 OI: Earnings 7/19 $22.22 Ref
    Conn's Inc (NASDAQ: CONN) Jan17 5.0 Puts Sweep: 605 @ ASK $0.85: 1355 traded vs 3132 OI: $7.16 Ref

    Posted-In: Huge Put PurchasesNews Options Markets

Top 10 Medical Stocks For 2018: Select Medical Holdings Corporation(SEM)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Overvalued companies include MWI Veterinary (MWIV) andStericycle (SRCL), while companies with attractive valuations include Cardinal Health (CAH), Selected Medical (SEM). He’s not a fan of Intrexon (XON) but callsAratana (PETX) a “hidden gem.”

Top 10 Medical Stocks For 2018: Tencent Holdings Ltd (700)

Advisors’ Opinion:

  • [By Belinda Cao]

    Sohu.com Inc. (SOHU), which sold a stake in its search unit to Tencent Holdings Ltd. (700), advanced 11 percent for the week to $72.06. It retreated 5.9 percent Sept. 20. Tencent, Chinas biggest Internet company by market value, paid $448 million for a 36.5 percent stake in Sohus Sogou unit last week and merge its own search service with Sogou.

Top 10 Medical Stocks For 2018: United Technologies Corporation(UTX)

Advisors’ Opinion:

  • [By Lisa Levin]

    United Technologies Corporation (NYSE: UTX) will acquire Rockwell Collins, Inc. (NYSE: COL) in a deal worth $30 billion , forging an aerospace behemoth producing virtually all types of avionics systems for commercial and defense aircraft.

  • [By Paul Ausick]

    United Technologies Corp. (NYSE: UTX) traded up 1.89% at $126.10. The stock’s 52-week range is $106.85 to $126.44 and the high was posted today. Volume was about 15% above the daily average of around 3 million. The company’s Pratt & Whitney division has won some big contracts in the last two day: one related to the Delta purchase of 100 Airbus planes and the other with the Pentagon for future maintenance of the company’s F119 engine.

  • [By Wayne Duggan]

    Aggressive military and law enforcement spending could be good news for Northrop Grumman Corporation (NYSE: NOC), United Technologies Corporation (NYSE: UTX), Lockheed Martin Corporation (NYSE: LMT), TASER International, Inc. (NASDAQ: TASR) and Digital Ally, Inc. (NASDAQ: DGLY).

  • [By WWW.THESTREET.COM]

    Coming up on this episode of Mad Money: Cramer interviews United Technologies (UTX) CEO Greg Hayes; and Doug Lebda, CEO of LendingTree (TREE) . Plus, don’t miss the Lightning Round. Which stocks is Cramer bullish on?

  • [By Paul Ausick]

    United Technologies Inc. (NYSE: UTX) traded up 1.35% at $118.45. The stock’s 52-week range is $96.89 to $119.258, and the high was posted this afternoon. Volume was about a third higher than the daily average of around 3 million. The industrial giant reported results this morning that were better than estimates on both profits and revenues.

Top 10 Medical Stocks For 2018: Vanguard FTSE Developed Markets ETF (VEA)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of P-Solve Investments Ltd’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=P-Solve+Investments+Ltd

    These are the top 5 holdings of P-Solve Investments LtdVanguard S&P 500 (VOO) – 4,400,097 shares, 39.56% of the total portfolio. Shares added by 7.03%Vanguard FTSE Developed Markets (VEA) – 13,317,140 shares, 22.4% of the total portfolio. Shares added by 99.57%iShares Core S&P Small-Cap (IJR) – 6,494,318 shares, 18.51% of the total portfolio. Shares added by 0.65%SPDR S&P 500 (SPY) – 669,450 shares, 6.55% of the total portfolio. Shares reduced by 12%Vanguard Total Stock Market (VTI) – 939,233 shares, 4.73% of th

Top 10 Medical Stocks For 2018: Uni-Pixel, Inc.(UNXL)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Uni-Pixel (UNXL) manufactures electronic film products using its proprietary manufacturing process, UniBoss. This stock closed up 7.6% to $16.84 in Monday’s trading session.

    Monday’s Volume: 1.88 million

    Three-Month Average Volume: 1 million

    Volume % Change: 108%

    From a technical perspective, UNXL bounced sharply higher here right off its 50-day moving average of $15.89 with above-average volume. This stock looks to be forming a double bottom chart pattern at $14.91 to $15.16. If that bottom holds, then shares of UNXL could see a continuation of Monday’s upside action.

    Traders should now look for long-biased trades in UNXL as long as it’s trending above $15.16 or $14.91 and then once it sustains a move or close above Monday’s high of $17.53 with volume that hits near or above 1 million shares. If we get that move soon, then UNXL will set up to re-test or possibly take out its next major overhead resistance level at its 200-day moving average of $19.89.

  • [By Lisa Levin]

    Shares of UniPixel Inc (NASDAQ: UNXL) were down 22 percent to $1.63 after the company announced a public offering of newly issued shares of stock. UniPixel plans to offer 5.35 million shares of its own stock at a public offering price of $1.50 per share with the option for its underwriters to purchase up to an additional 802,500 shares.

  • [By Peter Graham]

    Small cap sensor film stockUniPixel Inc (NASDAQ: UNXL) reportedQ1 2017 earnings after the Thursday market close withshares falling both on Thursday and in afterhours trading. UniPixel is not well covered or known by analysts yet and this can make shares volatile. However and last September, we had suggested a long position in the stock based upon technicals by saying:

  • [By Peter Graham]

    Small cap sensor film stock UniPixel Inc (NASDAQ: UNXL) is sinking by a double digit percentage in after-hours and pre-market trading after reporting Q4 earnings. The problem for UniPixel is that only a few analysts cover the small cap stock and the bottom line loss was a bit worst than the 10 cent loss they were expecting. The stock also had a slight uptick ahead of earnings:

Top 10 Medical Stocks For 2018: Intercept Pharmaceuticals, Inc.(ICPT)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap liver biopharmaceutical stock Intercept Pharmaceuticals Inc (NASDAQ: ICPT) reportedQ2 2017 earnings before the market opened on Monday with both the top and bottom lines beating expectations plus the Companyreported that amid-stage clinical trial met its primary endpoint; but sharesended the day down13.26%. Intercept Pharmaceuticals recognized $30.4 million of net sales of Ocaliva for Q2 2017 versus $75k and a net loss of $86.6 million versus a net loss of $77.3 million. Ocaliva was approved by the U.S.FDA in May 2016 for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA or as monotherapy in adults unable to tolerate UDCA. As of June 30, 2017,the Companyhad cash, cash equivalents and investment securities available for sale of approximately $550.3 million versus$689.4 million as of December 31, 2016. The CEO commented:

  • [By Paul Ausick]

    Intercept Pharmaceuticals Inc. (NASDAQ: ICPT) dropped more than 17% Friday to post a new 52-week low of $60.97 after closing Thursday at $73.70. The 52-week high is $172.75. Volume of more than 10 million shares traded was about 12 times the daily average. The FDA on Thursday issued a warning letter on the company’s liver disease treatment.

Top 10 Medical Stocks For 2018: Travelzoo Inc.(TZOO)

Advisors’ Opinion:

  • [By Casey Wilson]

    Year to date, the company’s stock price has fallen over 42%. Meanwhile, its competitors’ share prices have increased during the same period. The Travelzoo Inc. (Nasdaq: TZOO) share price has gained 41% YTD, and Priceline Group Inc. (Nasdaq: PCLN) has gained over 19%.